The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population,
Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C
November 30, 2013 – On the occasion of World AIDS Day 2013, HIV treatment activists from the MENA region called on wealthy Gulf States to join the Global Fund donor’s community sharing responsibility
BY NICHOLAS CIMARUSTI SEPTEMBER 27 2013 The UNAIDS released its 2013 global HIV/AIDS report Monday. Its figures estimate a possible end to the AIDS epidemic by 2030, which would also affect pharmaceutical companies.
The five viruses that cause infections of the liver are responsible for a widely prevalent and growing disease burden. No country, rich or poor, is spared. These viruses are important as they cause
The Middle East/North Africa (MENA) region is in turmoil. The trajectory and consequences of the current political, social and economic transformations rippling across the region will become clear in the years ahead. Meanwhile,
